Overall, there was no distinct difference in the FGFR1 frequencies across tumor characteristics between FGFR1-negative and positive expression groups in tumor-adjacent tissues except for the few patients that with positive FGFR1 levels in tumor-adjacent tissue appeared more likely to have progesterone receptor (PR) positive tumors. This evidence concerns the gene FGFR1 and neoplasm.